T. Mahon

发表

Directed evolution of human T-cell receptors with picomolar affinities by phage display

Yi Li, Ruth Moysey, Bent K Jakobsen, 2005, Nature Biotechnology.

Monoclonal TCR-redirected tumor cell killing

Yvonne McGrath, Yi Li, Bent K Jakobsen, 2012, Nature Medicine.

Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors

Emma L Henderson, J. Kumaran, L. Bawden, 2021, JCI insight.

Evidence for a redox-sensitive protein tyrosine kinase in nuclear factor kappa B activation and interleukin 2 production in EL4.NOB1 cells.

L. O’Neill, T. Mahon, P. Brennan, 1993, Biochemical Society transactions.

Receptors Tumor Cells Using High Affinity T Cell NY-ESO-1 / LAGE-1-Derived Epitopes on Quantifying and Imaging

J. E. Brewer, P. Vyas, J. Karbach, 2006 .

Bruton's Tyrosine Kinase Is Required For Lipopolysaccharide-induced Tumor Necrosis Factor α Production

H. Mano, F. Brennan, N. Horwood, 2003, The Journal of experimental medicine.

Bruton’s Tyrosine Kinase Is Required For Lipopolysaccharide-induced Tumor Necrosis Factor (cid:2) Production

H. Mano, F. Brennan, N. Horwood, 2003 .

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

B. Jakobsen, P. Molloy, L. Dorrell, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Engineered affinity-enhanced immune-mobilising monoclonal T cell receptors (ImmTAVs) for HIV cure

B. Jakobsen, J. Frater, L. Dorrell, 2017 .

Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production1

F. Brennan, N. Horwood, J. Campbell, 2006, The Journal of Immunology.

Production IL-6 , TLR 2 and TLR 4-Induced TNF , but Not Bruton ' s Tyrosine Kinase Is Required for

N. Horwood, J. Campbell, Christine D. Palmer, 2006 .

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

R. Phillips, C. June, A. Sewell, 2008, Nature Medicine.

Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy

Bent K. Jakobsen, B. Jakobsen, J. Dukes, 2016, Scientific Reports.

Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

Bent K. Jakobsen, Richard A. Morgan, Steven A. Rosenberg, 2008, The Journal of Immunology.

Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors

Bent K Jakobsen, J. E. Brewer, Marco A Purbhoo, 2006, The Journal of Immunology.

Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide‐MHC without increasing apparent cross‐reactivity

Yi Li, Feng Gao, Ruth Moysey, 2006, Protein science : a publication of the Protein Society.

Studies into the Effect of the Tyrosine Kinase Inhibitor Herbimycin A on NF-κB Activation in T Lymphocytes EVIDENCE FOR COVALENT MODIFICATION OF THE p50 SUBUNIT (*)

L. O’Neill, T. Mahon, 1995, The Journal of Biological Chemistry.

Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

G. Linette, M. Kalos, C. June, 2014 .

Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

C. June, A. Sewell, M. Purbhoo, 2008, Nature Medicine.

Monoclonal TCR-redirected tumor cell killing

M. Kalos, C. June, A. Sewell, 2012, Nature Medicine.